Tubeless percutaneous nephrolithotomy for complex renal stone disease

single center experience.

John B. Malcolm, Ithaar H. Derweesh, E. Keith Brightbill, Reza Mehrazin, Christopher J. DiBlasio, Robert Wake

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Tubeless percutaneous nephrolithotomy (PCNL) has become an option for treatment of renal stone disease, though no clearly defined algorithm exists for selection of patients suitable to tubeless PCNL. We investigated our experience with tubeless PCNL to evaluate its safety and efficacy for cases of complex renal calculi. Retrospective review of all tubeless PCNLs performed for complex renal calculus disease (bilateral stones, partial/complete staghorn, infundibular stenosis/calyceal diverticulum, pre-existing renal insufficiency) between January 2001 and January 2006. All patients had a ureteral stent placed in an antegrade fashion following stone treatment, and a foley catheter remained in place overnight. No patient received nephrostomy tube (NT). Imaging (CT or KUB) was obtained at the first outpatient follow-up visit. Patient demographics, incidence of complications, clinical outcomes and stone-free rates were noted and analyzed. "Stone free" was defined as negative imaging (CT or KUB). Forty-two patients (47 renal units) were treated with tubeless PCNL for complex renal stone disease (5 bilateral, 25 total/partial staghorn, 12 renal insufficiency, and 10 infundibular stenosis or calyceal diverticulum). Mean age was 58.2+/-9.4 years. Mean length of hospital stay was 2.1 days. Mean preoperative and postoperative hematocrit were 40.5+/-4.5 and 37.2+/-5.8, respectively (p=0.001). Single-procedure stone free rate was 74.5%, and the two-procedure stone free rate was 91.5%. One patient (2.4%) required a blood transfusion and one patient (2.4%) developed urosepsis. Tubeless PCNL is safe and effective and can be utilized in cases of complex renal stone disease.

Original languageEnglish (US)
JournalCanadian Journal of Urology
Volume15
Issue number3
StatePublished - Jun 2008

Fingerprint

Percutaneous Nephrostomy
Kidney
Kidney Calculi
Diverticulum
Renal Insufficiency
Length of Stay
Pathologic Constriction
Hematocrit
Blood Transfusion
Patient Selection
Stents
Outpatients
Catheters
Demography
Safety
Incidence
Therapeutics

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Malcolm, J. B., Derweesh, I. H., Brightbill, E. K., Mehrazin, R., DiBlasio, C. J., & Wake, R. (2008). Tubeless percutaneous nephrolithotomy for complex renal stone disease: single center experience. Canadian Journal of Urology, 15(3).

Tubeless percutaneous nephrolithotomy for complex renal stone disease : single center experience. / Malcolm, John B.; Derweesh, Ithaar H.; Brightbill, E. Keith; Mehrazin, Reza; DiBlasio, Christopher J.; Wake, Robert.

In: Canadian Journal of Urology, Vol. 15, No. 3, 06.2008.

Research output: Contribution to journalArticle

Malcolm, JB, Derweesh, IH, Brightbill, EK, Mehrazin, R, DiBlasio, CJ & Wake, R 2008, 'Tubeless percutaneous nephrolithotomy for complex renal stone disease: single center experience.', Canadian Journal of Urology, vol. 15, no. 3.
Malcolm, John B. ; Derweesh, Ithaar H. ; Brightbill, E. Keith ; Mehrazin, Reza ; DiBlasio, Christopher J. ; Wake, Robert. / Tubeless percutaneous nephrolithotomy for complex renal stone disease : single center experience. In: Canadian Journal of Urology. 2008 ; Vol. 15, No. 3.
@article{46c87800d6c14b67a9fd9a2c76b9f1a2,
title = "Tubeless percutaneous nephrolithotomy for complex renal stone disease: single center experience.",
abstract = "Tubeless percutaneous nephrolithotomy (PCNL) has become an option for treatment of renal stone disease, though no clearly defined algorithm exists for selection of patients suitable to tubeless PCNL. We investigated our experience with tubeless PCNL to evaluate its safety and efficacy for cases of complex renal calculi. Retrospective review of all tubeless PCNLs performed for complex renal calculus disease (bilateral stones, partial/complete staghorn, infundibular stenosis/calyceal diverticulum, pre-existing renal insufficiency) between January 2001 and January 2006. All patients had a ureteral stent placed in an antegrade fashion following stone treatment, and a foley catheter remained in place overnight. No patient received nephrostomy tube (NT). Imaging (CT or KUB) was obtained at the first outpatient follow-up visit. Patient demographics, incidence of complications, clinical outcomes and stone-free rates were noted and analyzed. {"}Stone free{"} was defined as negative imaging (CT or KUB). Forty-two patients (47 renal units) were treated with tubeless PCNL for complex renal stone disease (5 bilateral, 25 total/partial staghorn, 12 renal insufficiency, and 10 infundibular stenosis or calyceal diverticulum). Mean age was 58.2+/-9.4 years. Mean length of hospital stay was 2.1 days. Mean preoperative and postoperative hematocrit were 40.5+/-4.5 and 37.2+/-5.8, respectively (p=0.001). Single-procedure stone free rate was 74.5{\%}, and the two-procedure stone free rate was 91.5{\%}. One patient (2.4{\%}) required a blood transfusion and one patient (2.4{\%}) developed urosepsis. Tubeless PCNL is safe and effective and can be utilized in cases of complex renal stone disease.",
author = "Malcolm, {John B.} and Derweesh, {Ithaar H.} and Brightbill, {E. Keith} and Reza Mehrazin and DiBlasio, {Christopher J.} and Robert Wake",
year = "2008",
month = "6",
language = "English (US)",
volume = "15",
journal = "Canadian Journal of Urology",
issn = "1195-9479",
publisher = "Canadian Journal of Urology",
number = "3",

}

TY - JOUR

T1 - Tubeless percutaneous nephrolithotomy for complex renal stone disease

T2 - single center experience.

AU - Malcolm, John B.

AU - Derweesh, Ithaar H.

AU - Brightbill, E. Keith

AU - Mehrazin, Reza

AU - DiBlasio, Christopher J.

AU - Wake, Robert

PY - 2008/6

Y1 - 2008/6

N2 - Tubeless percutaneous nephrolithotomy (PCNL) has become an option for treatment of renal stone disease, though no clearly defined algorithm exists for selection of patients suitable to tubeless PCNL. We investigated our experience with tubeless PCNL to evaluate its safety and efficacy for cases of complex renal calculi. Retrospective review of all tubeless PCNLs performed for complex renal calculus disease (bilateral stones, partial/complete staghorn, infundibular stenosis/calyceal diverticulum, pre-existing renal insufficiency) between January 2001 and January 2006. All patients had a ureteral stent placed in an antegrade fashion following stone treatment, and a foley catheter remained in place overnight. No patient received nephrostomy tube (NT). Imaging (CT or KUB) was obtained at the first outpatient follow-up visit. Patient demographics, incidence of complications, clinical outcomes and stone-free rates were noted and analyzed. "Stone free" was defined as negative imaging (CT or KUB). Forty-two patients (47 renal units) were treated with tubeless PCNL for complex renal stone disease (5 bilateral, 25 total/partial staghorn, 12 renal insufficiency, and 10 infundibular stenosis or calyceal diverticulum). Mean age was 58.2+/-9.4 years. Mean length of hospital stay was 2.1 days. Mean preoperative and postoperative hematocrit were 40.5+/-4.5 and 37.2+/-5.8, respectively (p=0.001). Single-procedure stone free rate was 74.5%, and the two-procedure stone free rate was 91.5%. One patient (2.4%) required a blood transfusion and one patient (2.4%) developed urosepsis. Tubeless PCNL is safe and effective and can be utilized in cases of complex renal stone disease.

AB - Tubeless percutaneous nephrolithotomy (PCNL) has become an option for treatment of renal stone disease, though no clearly defined algorithm exists for selection of patients suitable to tubeless PCNL. We investigated our experience with tubeless PCNL to evaluate its safety and efficacy for cases of complex renal calculi. Retrospective review of all tubeless PCNLs performed for complex renal calculus disease (bilateral stones, partial/complete staghorn, infundibular stenosis/calyceal diverticulum, pre-existing renal insufficiency) between January 2001 and January 2006. All patients had a ureteral stent placed in an antegrade fashion following stone treatment, and a foley catheter remained in place overnight. No patient received nephrostomy tube (NT). Imaging (CT or KUB) was obtained at the first outpatient follow-up visit. Patient demographics, incidence of complications, clinical outcomes and stone-free rates were noted and analyzed. "Stone free" was defined as negative imaging (CT or KUB). Forty-two patients (47 renal units) were treated with tubeless PCNL for complex renal stone disease (5 bilateral, 25 total/partial staghorn, 12 renal insufficiency, and 10 infundibular stenosis or calyceal diverticulum). Mean age was 58.2+/-9.4 years. Mean length of hospital stay was 2.1 days. Mean preoperative and postoperative hematocrit were 40.5+/-4.5 and 37.2+/-5.8, respectively (p=0.001). Single-procedure stone free rate was 74.5%, and the two-procedure stone free rate was 91.5%. One patient (2.4%) required a blood transfusion and one patient (2.4%) developed urosepsis. Tubeless PCNL is safe and effective and can be utilized in cases of complex renal stone disease.

UR - http://www.scopus.com/inward/record.url?scp=70350013078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350013078&partnerID=8YFLogxK

M3 - Article

VL - 15

JO - Canadian Journal of Urology

JF - Canadian Journal of Urology

SN - 1195-9479

IS - 3

ER -